During a Case-Based Roundtable® event, Matthew Campbell, MD, MS, moderated a discussion on treatment for a 61-year-old ...

Media Release Mature data in patients with a minimum follow-up of 22 months (N=21) shows excellent results, well above historical controls and exceeding expectations: Median Overall Survival is 32.9 ...

With careful targeting, SBRT aims to destroy cancer cells while sparing surrounding tissues, commonly treating early-stage ...

Thursday announced positive data from INSIGHT-003 Phase I trial, evaluating the addition of Eftilagimod alpha or ...

Media ReleaseMature data in patients with a minimum follow-up of 22 months (N=21) shows excellent results, well above historical controls and ...

Associate professor Satoshi Watanabe and his teams from Niigata University have revealed that PET/CT image analysis using ...

A 41-year-old Dunwoody mom who never smoked a day in her life was diagnosed with terminal stage 4 lung cancer.

A research team has shown that that combining pembrolizumab, an immunotherapy drug, with standard chemotherapy can improve treatment outcomes for patients with small cell bladder cancer and small cell ...

In a new study of patients with metastatic non-small cell lung cancer, researchers found that patients who were more physically fit had better outcomes. With lung cancer claiming around 1.8 million ...

Interstitial lung disease is characterized by scarring (fibrosis ... Dr. Yamazaki says, "PET/CT is generally performed to ...

Patients with metastatic non-small cell lung cancer, even those with brain metastases, experienced improved longer-term ...